M. Cici Et Al. , "Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model," Biotechnic and Histochemistry , vol.99, no.2, pp.76-83, 2024
Cici, M. Et Al. 2024. Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model. Biotechnic and Histochemistry , vol.99, no.2 , 76-83.
Cici, M., Dilmac, S., Aytac, G., & TANRIÖVER, G., (2024). Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model. Biotechnic and Histochemistry , vol.99, no.2, 76-83.
Cici, Mansur Et Al. "Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model," Biotechnic and Histochemistry , vol.99, no.2, 76-83, 2024
Cici, Mansur Et Al. "Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model." Biotechnic and Histochemistry , vol.99, no.2, pp.76-83, 2024
Cici, M. Et Al. (2024) . "Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model." Biotechnic and Histochemistry , vol.99, no.2, pp.76-83.
@article{article, author={Mansur Cici Et Al. }, title={Cerebral cavernous malformation proteins, CCM1, CCM2 and CCM3, are decreased in metastatic lesions in a murine breast carcinoma model}, journal={Biotechnic and Histochemistry}, year=2024, pages={76-83} }